Health is our business

New Strategies in the Treatment of Antibiotic-Resistant

Webinar

By ادمین بهستان 3 Oct/ 0 Comment

New Strategies in the Treatment of Antibiotic-Resistant Gram-Negative Infections




Scientific webinar on new solutions in the treatment of antibiotic-resistant gram-negative infections, Pfizer's anti-infective team

The program was held in collaboration with Isfahan University of Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, and Mashhad University of Medical Sciences with three retraining points for participants from different groups (Infectious Diseases, Intensive Care, Lung, Internal Medicine) and in the presence of more than 120 professors and residents.

At first, Dr. Farzin Khorvash (Infectious Diseases Specialist of Al-Zahra Hospital, Isfahan) welcomed the audience and reviewed "new treatment strategies for infections caused by Acinetobacter baumannii" and then expressed the effect of Tygacil on the treatment of these infections. Then, Dr. Mohammad Reza Salehi (Infectious Diseases Specialist and Hospital Infections Fellowship from Imam Khomeini Hospital, Tehran) spoke about "Management of ventilator-associated pneumonia caused by gram-negative microorganisms." Dr. Sara Abolghasemi (Infectious Diseases Specialist and Infectious Diseases Fellowship from Labbafinejad Hospital) presented her articles on "Known and emerging mechanisms of antimicrobial resistance in gram-negative bacteria" and gave a full introduction to the Tygacil drug. She gave a comprehensive explanation about the mechanism of the effect of Tygacil unique effect, indications, its effect on resistant gram-negative infections, drug forms and how to use it, which was welcomed by the audience. Also, Dr. Rozita Khodashahi (Infectious Diseases Specialist and Infectious Diseases Fellowship from Imam Reza Hospital in Mashhad) raised the topic of "New treatment strategies for infections caused by Klebsiella pneumoniae (manufacturer) of carbapenemaz". At the end of the webinar, the audience's questions about the issues raised and the Tygacil drug were answered.

Share
Submit a comment